Stephanie Arnett/MITTR | Envato

The first CRISPR cure might kick-start the next big patent battle

Published On: December 8, 2023Categories: Biotechnology, Hot Topics

That’s a real nice CRISPR cure you have there. It would be a pity if anything happened to it.

Okay. Drop the tough-guy accent and toss the black fedora aside. But I do believe that similar conversations could be occurring now that a historic gene-editing cure is coming to market, as soon as this year.

By the middle of December, Vertex Pharmaceuticals, based in Boston, is expected to receive FDA approval to sell a revolutionary new treatment for sickle-cell disease that’s the first to use CRISPR to alter the DNA inside human cells. (Vertex has already received regulatory approval in the UK.)

Full Article

news via inbox

Stay on the cutting edge of medicine with the PLMI Newsletter.